CVS Health Corporation
CVS
$66.97
-$0.88-1.30%
NYSE
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
P/E (TTM)
EPS (TTM)
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 8.21% | 1,789.66% | -95.08% | 59.03% | -45.60% |
| Total Depreciation and Amortization | 0.61% | -1.21% | 0.87% | 1.14% | 0.35% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 136.50% | -239.12% | 5,414.29% | 110.14% | -130.26% |
| Change in Net Operating Assets | 462.18% | 83.44% | -1,577.64% | -94.08% | 145.02% |
| Cash from Operations | 144.95% | 349.66% | -124.12% | -37.00% | 286.00% |
| Capital Expenditure | 3.26% | -14.63% | -5.02% | 9.50% | 22.61% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -100.00% | 16.67% | 75.00% | -92.00% | 79.17% |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -99.57% | 108.67% | -183.81% | 31.16% | -546.45% |
| Cash from Investing | -39.31% | 83.66% | -105.97% | 22.40% | -68.60% |
| Total Debt Issued | -- | 612.17% | -75.41% | -3.14% | 1,159.50% |
| Total Debt Repaid | 47.77% | -108.78% | -570.78% | -1,116.67% | 95.83% |
| Issuance of Common Stock | 657.89% | -83.33% | 356.00% | -87.68% | 480.00% |
| Repurchase of Common Stock | -175.00% | 0.00% | 97.18% | 95.36% | -61,060.00% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -0.24% | -0.12% | 2.45% | -2.14% | -7.83% |
| Other Financing Activities | -147.92% | 500.00% | 166.67% | 109.09% | -466.67% |
| Cash from Financing | -641.07% | 127.14% | -227.14% | 201.79% | -26.23% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -16.17% | 130.70% | -309.36% | 71.49% | 132.62% |